Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Undefined offset: 0 in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10

Notice: Trying to get property 'name' of non-object in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10
2019 Frontiers in Cancer Immunotherapy
stdClass Object ( [getLoginUrlResponse] => stdClass Object ( [JSESSIONID] => 4D059026FA44F15012ACE8AB79B57203.app30061b [routing_id] => 00000000.app30061b [url] => https://give.cancerresearch.org/site/CRConsAPI;jsessionid=00000000.app30061b?NONCE_TOKEN=77EF1C5A3927C349A4CC660AC8BBFF5F [token] => fM7hqp8tM_kwvWYaTCTeSW-v9x3JDH5GlQT0qhQ2hqqQz8g9ZuRWoE2_I7aLYOM8TSEvR4RTZR4qViX9mNyz4QioGwdkp2E9xRQWPCQ ) ) test

Cancer Research Institute Event Calendar

Subscribe

Share

2019 Frontiers in Cancer Immunotherapy

Immuno-oncology promises a revolution in the way we treat cancer. Since the approval of the first checkpoint inhibitors in 2014, and the subsequent approval of the first cellular therapy in 2017, the field of cancer immunotherapy has exploded with numerous ongoing clinical trials. Despite great successes, emerging results suggest that monotherapies are not sufficient to treat many cancer types and it is increasingly clear that combinatorial approaches are needed to target heterogeneous tumors and improve variability in patient response.

This two-day symposium will convene leading experts in cancer immunotherapy to discuss cutting-edge findings in the broad area of combination therapies, including checkpoint inhibitors and cellular therapies. Particular emphasis will be given to the biological mechanisms underlying combination hypotheses, bispecific antibodies and other emerging modalities for delivery of combination therapies, as well as a discussion of the importance of biomarkers and effective clinical trial design.

Presented By

Cancer Discussion Group at The New York Academy of Sciences

Keynote Speaker

James P. Allison, Ph.D., MD Anderson Cancer Center 

Call for Abstracts

Abstract submissions are invited for a poster session. The deadline for abstract submission is Friday, March 15, 2019.

The Cancer Research Institute is a promotional partner for this event. 

The event will take place at The New York Academy of Sciences, 7 World Trade Center, 
250 Greenwich St, Floor 40, New York, NY.

Read more:

This site is registered on wpml.org as a development site.